Regeneron Pharmaceuticals, Inc.
Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells
Last updated:
Abstract:
Provided herein are compositions and methods for redirecting recombinant viral capsid particles via a specific protein:protein binding pair that forms an covalent, e.g., isopeptide, bond to display a targeting ligand on the capsid protein, wherein the targeting ligand specifically binds a cell surface marker expressed on the cell of interest.
Status:
Application
Type:
Utility
Filling date:
27 Jun 2018
Issue date:
7 May 2020